NUS Medicine Researchers Develop Potential Oral Anti-Diabetic Drug

Congratulations to Associate Professor Sim Meng Kwoon, retired faculty member of the Department of Pharmacology, at NUS Medicine, for developing an oral anti-diabetic drug and have successfully completed Phase I clinical trial. The drug improves the action of insulin and reduces damaging chronic inflammation that accompanies diabetes.

Leave a Comment

Your email address will not be published. Required fields are marked *